• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Pentasa Suppositories
    / Ferring Pharmaceuticals


    Active Ingredient

    Status in Israel
    RX

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft

    Suppositories

    28

    full basket chart 8879 16063

    Dosage

    1 suppository 1-2 times daily.


    Indications

    Ulcerative proctitis.


    Contra-Indications

    Hypersensitivity to mesalazine, any other component of the product or salicylates. Severe liver and/or renal impairment.


    Special Precautions

    Patients allergic to sulphasalazine (risk of allergy to salicylates).


    Side Effects

    N/A


    Drug interactions

    Aspirin, diphenhydramine, probenicid, isoniazide, rifamipicin.


    Manufacturer
    Ferring Pharmaceuticals
    CLOSE